The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers
Glenn J. Hanna*, Ji Eun Bae, Jochen H. Lorch, Robert I. Haddad, Vickie Y. Jo, Jonathan D. Schoenfeld, Danielle N. Margalit, Roy B. Tishler, Laura A. Goguen, Donald J. Annino, Nicole G. Chau
Dive into the research topics of 'The Benefits of Adjuvant Trastuzumab for HER-2-Positive Salivary Gland Cancers'. Together they form a unique fingerprint.